Tissue of Optic nerve under microscope, pink and purple colours

Glaucoma Learning Zone

Brinzolamide/brimonidine fixed-dose combination bid for open-angle glaucoma/ocular hypertension

Read time: 5 mins

Last updated: 12th Sep 2022

Published: 12th Sep 2022

Declaration of sponsorship: Novartis

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension

Brinzolamidebrimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucomaocular hypertension

Pdf, 11.76 MB

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information

Name

Email address

Specialty

By providing your email address, you are opting in to receive our monthly newsletter.

Opt-in: By selecting this box, I consent to receiving marketing communications and information about Medthority's resources by email.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.